IFNA1 and COVID-19: While a fraction of severely COVID-19 patients is highly suppressed in their IFN production and activity due to genetic defects, the presence of anti-IFN auto-Abs or other causes (9–12), on the other hand, delayed and disproportionate IFN responses are involved in the progression to severe disease (4, 13, 14).